Latest Breaking News On - Trademark office on feb - Page 1 : comparemela.com

Adial Pharmaceuticals said the patent was awarded by the United States Patent and Trademark Office on Feb. 20 and covers the company's lead investigational new drug product, AD04, and its ability to target the serotonin transporter gene for the potential treatment of opioid use disorder. Benzinga broke the news first Wednesday morning with an exclusive report before the opening bell.

United statesCary claiborneTrademark office on febAdial pharmaceuticalsAdial pharmaceuticals incUnited states patentTrademark officeIntellectual propertyBenzinga proBiotech stocks surge to startCharts look greatWill the trend